Dr Reddy's Launches Levetiracetam in Sodium Chloride Inj in USA | CORPORATE ETHOS

Dr Reddy’s Launches Levetiracetam in Sodium Chloride Inj in USA

By: | June 19, 2018

Jun 19: Hyderabad-based drug maker Dr Reddy’s Laboratories Ltd on Tuesday said that it has launched Levetiracetram in Sodium Chloride Injection, 500 mg/100 ml (5 mg/ml), 1,000 mg/100 ml (10 mg/ml), and 1,500 mg/100 ml (15 mg/ml) single-dose infusion bags, a therapeutic equivalent generic version of HQ Specialty Pharma Corporation’s Levetiracetam in Sodium Chloride Injection, approved by the US Food and Drug Administration (USFDA).

The Levetiracetam in Sodium Chloride Injection brand and generic had US sales of approximately $37 million MAT for the most recent twelve months ending in April 2018 according to IMS Health.

Dr Reddy’s shares were trading at Rs 2,399, up 0.79% from the previous closing of Rs 2,380.25, on BSE at 12.55 pm today